◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Alfresa Holdings Corporation (2784)
来自官方财务报表的收入、利润与现金流历史。
Healthcare · 华尔街（美国） · 最近更新： 2026-08-10
Alfresa Holdings Corporation 通过其子公司在日本和国际上从事药品、诊断试剂和医疗器械/设备的制造、批发、营销和进出口业务。还涉足配药店的经营及开展相关业务；道德药品批发业务；自我药疗产品批发业务；以及其他医疗相关业务。此外，该公司还生产和销售活性药物成分；医院的合同分销服务；信息系统的运营、维护、开发；电池原料供应；特定加工细胞和再生医学产品的制造。该公司成立于 2003 年，总部位于日本东京。
机器翻译
关键数据
- 市值: JPY 385 billion
- 收入（截至 2026-03-31 财年）: JPY 3.10T
- 净利润: JPY 41.7B
- 毛利率: 7.0%
- 净利率: 1.3%
查看交互式图表与完整报表 →
年度利润表
| 利润表 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|
| 总收入 | JPY 3.10T | JPY 2.96T | JPY 2.86T | JPY 2.70T | — |
| 毛利 | JPY 217.9B | JPY 213.9B | JPY 206.4B | JPY 192.1B | — |
| 营业利润（EBIT） | JPY 36.2B | JPY 38.1B | JPY 38.5B | JPY 30.1B | — |
| 净利 | JPY 41.7B | JPY 27.4B | JPY 29.6B | JPY 25.8B | — |
来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。
资产负债表、现金流、季度数据与完整财务比率见 2784 交互式查看器。 /companies/us/2784
类似公司
本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。
About TickerBase · Data methodology & sources · Privacy · Terms
TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.